FrancophonIA/ELRC3.0 huggingface dataset:
English: See section 6.5 for the number of doses per container.
Croatian: Vidjeti dio 6.5 za broj doza po spremniku.
English: The immunisation schedules for Prevenar 13 should be based on official recommendations.
Croatian: Rasporedi imunizacije Prevenarom 13 trebaju se temeljiti na službenim preporukama.
English: One single dose.
Croatian: Jedna jednokratna doza.
English: According to official recommendations in your country, an alternative schedule may be used by your healthcare provider.
Croatian: Ovisno o službenim preporukama u Vašoj zemlji, liječnik može primijeniti i alternativni raspored cijepljenja.
English: 2004 data.
Croatian: Podaci iz 2004. g.
English: This does not constitute a sign of deterioration.
Croatian: Ovi znakovi ne ukazuju na kvarenje.
English: • if you or your child is allergic (hypersensitive) to the active substances or to any of the other ingredients in this medicine (listed in section 6) or to any other vaccine that contains diphtheria toxoid.
Croatian: • ako ste Vi ili Vaše dijete alergični (preosjetljivi) na djelatne tvari, bilo koji drugi sastojak ovog lijeka (naveden u dijelu 6.) ili bilo koje drugo cjepivo koje sadrži toksoid difterije.
English: Do not administer intravascularly.
Croatian: Nemojte ga primijeniti intravaskularno.
English: oC. Other in-use storage times and conditions are the responsibility of the user.
Croatian: Ostalo vrijeme i uvjeti pohrane tijekom primjene odgovornost su korisnika.
English: The frequency is defined as follows: very common ( 1/10), common ( 1/100 to < 1/10), uncommon ( 1/1,000 to < 1/100), rare ( 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from available data).
Croatian: Učestalost je definirana na sljedeći način: vrlo često ( 1/10), često ( 1/100 i < 1/10), manje često ( 1/1000 i < 1/100), rijetko ( 1/10 000 i < 1/1000), vrlo rijetko (≤ 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
English: Prevenar 13 has no or negligible influence on the ability to drive and use machines.
Croatian: Prevenar 13 ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: 23 to 2948
Croatian: 23 do 2948
English: USA (2000)
Croatian: S.A.D. (2000)
English: A reduction in carriage was also seen for serotype 3 (2.5% vs 1.1%; p=0.1).
Croatian: Smanjenje kliconoštva je zabilježeno i za serotip 3 (2,5% naspram 1,1%; p=0,1).
English: See sections 4.4 and 5.1 for information on protection against specific pneumococcal serotypes.
Croatian: Vidjeti dijelove 4.4 i 5.1 za podatke o zaštiti od specifičnih serotipova pneumokoka.
English: Vaccine efficacy October 1995 to April 20, 1999 October 1995 to April 30, 1998
Croatian: Od listopada 1995. do 20. travnja 1999. g. Od listopada 1995. do 30. travnja 1998. g.
English: Immune responses in Special Populations
Croatian: Imunološki odgovori u posebnim populacijama
English: Because these reactions were derived from spontaneous reports, the frequencies could not be determined and are thus considered as not known.
Croatian: Budući da su ove nuspojave bile spontano prijavljene, njihova se učestalost nije mogla utvrditi i stoga se smatra nepoznatom.
English: In children and adolescents aged 6 to 17 years, the incidence of pneumococcal disease is low, however, there is an increased risk of morbidity and mortality in those with underlying comorbidities.
Croatian: Kod djece i adolescenata u dobi od 6 do 17 godina, incidencija pneumokoknih bolesti je niska, međutim, postoji povećan rizik morbiditeta i mortaliteta kod onih s prisutnim komorbiditetom.
English: The doctor or nurse will inject the recommended dose (0.5 ml) of the vaccine into your arm or your child's arm or leg muscle.
Croatian: Liječnik ili medicinska sestra ubrizgat će Vam preporučenu dozu (0,5 ml) cjepiva u mišić na ruci ili Vašem djetetu u mišić na ruci ili nozi.
English: First episode of VT-IPD
Croatian: Prva epizoda VT-IPD-a
English: Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, single and repeated dose toxicity, local tolerance, and reproduction and developmental toxicity.
Croatian: Neklinički podaci ne ukazuju na poseban rizik za ljude na temelju konvencionalnih ispitivanja sigurnosne farmakologije, toksičnosti jednokratne i ponovljenih doza, lokalne podnošljivosti i reproduktivne i razvojne toksičnosti.
English: Hypotonic-hyporesponsive episode
Croatian: hipotono-hiporesponzivna epizoda
English: Other adverse events previously observed in infants and children 6 weeks to 5 years of age may also be applicable to this age group but were not seen in this study possibly due to the small sample size.
Croatian: Ostali štetni događaji koji su prethodno primijećeni kod dojenčadi i djece u dobi od 6 tjedana do 5 godina mogu se pojaviti i kod ove dobne skupine, no u ovom ispitivanju nisu primijećeni najvjerojatnije zbog male veličine uzorka.
English: The study demonstrated that safety and immunogenicity were generally comparable with observations made in studies of intramuscular administration.
Croatian: Ispitivanje je pokazalo da su sigurnost i imunogenost općenito bile usporedive s opažanjima u ispitivanjima intramuskularne primjene.
English: If this applies to you or your child, then the vaccination will be postponed until you or your child is feeling better.
Croatian: Ako se ovo odnosi na Vas ili Vaše dijete, onda će cijepljenje biti odgođeno dok se stanje ne poboljša.
English: 4 x 0.5 ml doses
Croatian: 4 x 0,5 ml doze
English: Prevenar 13 can be given at the same time as other childhood vaccines; in this case, different vaccination sites should be used.
Croatian: Prevenar 13 se može dati istodobno s drugim cjepivima za djecu; u tom slučaju potrebno je odabrati različita mjesta primjene.
English: 18 to 381
Croatian: 18 do 381
English: Additional information in special populations
Croatian: Dodatne informacije za posebne populacije
English: 5 to 186
Croatian: 5 do 186
English: Conjugated to CRM197 carrier protein, adsorbed on aluminium phosphate.
Croatian: Konjugirani na proteinski nosač CRM197, adsorbirani na aluminijev fosfat.
English: Tell your doctor, pharmacist or nurse if you or your child is taking, has recently taken or might take any other medicines, or has recently received any other vaccine.
Croatian: Obavijestite svog liječnika, ljekarnika ili medicinsku sestru ako Vi ili Vaše dijete uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove, ili ako ste nedavno primili neko drugo cjepivo.
English: These data are intended to guide health care professionals in case of temporary temperature excursions.
Croatian: Ovi podaci služe kao uputa zdravstvenim radnicima u slučaju privremenih odstupanja temperature.
English: • Collapse or shock-like state (hypotonic-hyporesponsive episode)
Croatian: • kolaps ili stanje nalik šoku (hipotono-hiporesponzivna epizoda)
English: Complete effectiveness for routine 2+1 schedule not yet available.
Croatian: Od siječnja 2005. do prosinca 2007. g. Potpuna učinkovitost za rutinski raspored cijepljenja 2+1 još nije dostupna.
English: A third dose is recommended in the second year of life.
Croatian: Treća doza preporučuje se u drugoj godini života.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before receiving this medicine.
Croatian: Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku ili ljekarniku za savjet prije nego primite ovaj lijek.
English: Pharmacotherapeutic group: vaccines, pneumococcal vaccines; ATC code: J07AL02
Croatian: Farmakoterapijska skupina: cjepiva, pneumokokna cjepiva; ATK oznaka: J07AL02
English: Immune responses to the additional 6 serotypes were also measured.
Croatian: Mjereni su i imunološki odgovori na dodatnih 6 serotipova.
English: 9 to 122
Croatian: 9 do 122
English: 7-valent Prevenar
Croatian: 7-valentni Prevenar
English: The active substances are polysaccharide CRM197 conjugates consisting of:
Croatian: Djelatne tvari su polisaharidi konjugirani na CRM197 koji se sastoje od:
English: It is important to follow the instructions from the doctor, pharmacist, or nurse so that your child completes the course of injections.
Croatian: Važno je da se pridržavate uputa liječnika, ljekarnika ili medicinske sestre, tako da Vaše dijete primi sve injekcije cjepiva.
English: See also section 4.
Croatian: Pogledajte također dio 4.
English: 19 to 733
Croatian: 19 do 733
English: Safety was assessed in 7 clinical studies including 91,593 adults ranging in age from 18 to 101 years.
Croatian: Sigurnost je procijenjena u 7 kliničkih ispitivanja u koja je bilo uključeno 91 593 odraslih osoba u dobi od 18 do 101 godine.
English: Administer the entire dose.
Croatian: Primijenite cijelu dozu.
English: As the benefit of vaccination is high in this group of infants, vaccination should not be withheld or delayed.
Croatian: Budući da je korist od cijepljenja u ove skupine dojenčadi velika, cijepljenje ne bi trebalo uskratiti niti odgađati.
English: Pyrexia (very common in adults aged 18 to 29 years)
Croatian: pireksija (vrlo često u odraslih u dobi od 18 do 29 godina)
English: Infants, children, and adolescents previously vaccinated with Prevenar
Croatian: Dojenčad, djeca i adolescenti prethodno cijepljeni Prevenarom
English: All episodes analysis
Croatian: Analiza svih epizoda
English: In Table 6, NNV is a measure that quantifies the number of people that need to be vaccinated in order to prevent one clinical CAP case.
Croatian: U tablici 6 broj potrebnih cijepljenja je mjera koja određuje broj ljudi koje je potrebno cijepiti kako bi se spriječio jedan klinički slučaj CAP-a.
English: 20 to 1234
Croatian: 20 do 1234
English: As with other vaccines, the administration of Prevenar 13 should be postponed in subjects suffering from acute, severe febrile illness.
Croatian: Kao i kod svih drugih cjepiva, primjenu Prevenara 13 treba odgoditi u osoba koje boluju od teške, akutne febrilne bolesti.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
Croatian: SADRŽAJ PO MASI, VOLUMENU ILI BROJU JEDINICA LIJEKA
English: Functional antibody titers (OPA titers) were not measured in this study.
Croatian: Funkcionalni titri protutijela (OPA titri) nisu mjereni tijekom ovog ispitivanja.
English: What Prevenar 13 looks like and contents of the pack
Croatian: Kako Prevenar 13 izgleda i sadržaj pakiranja
English: These observations are consistent with adequate priming (the induction of immunologic memory).
Croatian: Ovi su nalazi sukladni s odgovarajućim primarnim cijepljenjem (indukcija imunološke memorije).
English: The most commonly reported adverse reactions in children 6 weeks to 5 years of age were vaccination-site reactions, fever, irritability, decreased appetite, and increased and/or decreased sleep.
Croatian: Najčešće zabilježene nuspojave kod djece od 6 tjedana starosti do 5 godina bile su reakcije na mjestu primjene cjepiva, vrućica, razdražljivost, smanjeni apetit i pretjerano i/ili smanjeno spavanje.
English: S. pneumoniae is the most frequent cause of CAP, and is estimated to be responsible for approximately 30% of all CAP cases requiring hospitalisation in adults in developed countries.
Croatian: S. pneumoniae je najčešći uzročnik izvanbolničke upale pluća i procjenjuje se da je odgovoran za otprilike 30% svih slučajeva izvanbolničke upale pluća koji su zahtijevali hospitalizaciju u odraslih u razvijenim zemljama.
English: In clinical studies, the safety profile of Prevenar 13 was similar to Prevenar.
Croatian: U kliničkim ispitivanjima, sigurnosni profil Prevenara 13 bio je sličan sigurnosnom profilu Prevenara.
English: Adults aged 50 years and older
Croatian: Odrasli u dobi od 50 godina i stariji
English: • has any present or past medical problems after any dose of Prevenar or Prevenar 13 such as an allergic reaction or problems with breathing.
Croatian: • imate ili ste imali neke zdravstvene probleme nakon bilo koje doze Prevenara ili Prevenara 13, kao što su alergijska reakcija ili tegobe s disanjem.
English: The immunogenicity after two doses in infants has been documented in four studies.
Croatian: Imunogenost nakon dvije doze u dojenčadi zabilježena je u četiri ispitivanja.
English: Invasive Pneumococcal Disease
Croatian: Invazivna pneumokokna bolest
English: Read all of this leaflet carefully before you or your child receives this vaccine because it contains important information for you.
Croatian: Vi ili Vaše dijete primite ovo cjepivo jer sadrži Vama važne podatke.
English: • has a weakened immune system (such as due to HIV infection), you/she/he may not get the full benefit from Prevenar 13.
Croatian: • imate oslabljeni imunološki sustav (kao kod HIV-infekcije), možda nećete imati potpunu korist od cijepljenja Prevenarom 13.
English: Additional information in special populations: Apnoea in very premature infants ( 28 weeks of gestation) (see section 4.4).
Croatian: Dodatne informacije za posebne populacije: Apneja u dojenčadi koja je vrlo rano rođena (nakon ≤ 28 tjedana gestacije) (vidjeti dio 4.4).
English: 6A 7F 19A The serotype in Prevenar with the lowest percent response rate was 6B in study 006 (87.1 %).
Croatian: 6A 7F 19A Serotip u Prevenaru s najnižim postotkom stope odgovora bio je 6B u ispitivanju 006 (87,1 %).
English: Children and adolescents aged 2-17 years One single dose of 0.5 ml.
Croatian: Djeca i adolescenti u dobi od 2 do 17 godina Jedna jednokratna doza od 0,5 ml.
English: Talk to your doctor, pharmacist, or nurse before the vaccination if you or your child:
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije cijepljenja ako Vi ili Vaše dijete:
English: * 95% CI inflated from a Poisson interval based on over-dispersion of 2.1 seen from modelling of 2000-06 pre-Prevenar all IPD data.
Croatian: * 95% CI uvećan Poissonovim intervalom temeljenim na prekomjernoj disperziji 2,1 promatranoj modeliranjem 2000-06 prije Prevenara svih podataka o invazivnoj pneumokoknoj bolesti.
English: In this age group, serotypes 1, 3, 5, 6A, 7F, and 19A account for 15.6% to 59.7% of invasive disease, depending on the country, the time period studied, and the use of Prevenar.
Croatian: U toj dobnoj skupini, serotipovi 1, 3, 5, 6A, 7F i 19A uzrokuju 15,6 % do 59,7 % invazivnih bolesti, ovisno o zemlji, promatranom vremenskom periodu i primjeni Prevenara.
English: Correspondingly, OPA GMTs were similar in both groups, except for serotype 3, which was lower, and serotype 18C, which was higher, in the group that received Prevenar 13 with 2-PE.
Croatian: Shodno tome, OPA GMT-ovi bili su slični u obje skupine, osim za serotip 3, koji je bio niži i serotip 18C, koji je bio viši u skupini koja je primala Prevenar 13 s 2-PE.
English: The clinical relevance of the antibody levels elicited by Prevenar 13 in these special populations is unknown.
Croatian: Klinički značaj razine antitijela izazvanih Prevenarom 13 u tim posebnim populacijama nije poznat.
English: Hampshire PO9 2NG United Kingdom
Croatian: Hampshire PO9 2NG Ujedinjeno Kraljevstvo
English: It will not protect against other infectious agents that can cause ear infections.
Croatian: Cjepivo neće zaštititi od drugih infektivnih uzročnika koji mogu uzrokovati infekcije uha.
English: Prevenar 13 must not be mixed with any other vaccines in the same syringe.
Croatian: Prevenar 13 ne smije se miješati s drugim cjepivima u istoj štrcaljki.
English: OPA titres are expressed as the reciprocal of the highest serum dilution that reduces survival of the pneumococci by at least 50 %.
Croatian: OPA titri bili su izraženi kao recipročna vrijednost najvećeg razrjeđenja seruma koje smanjuje preživljenje pneumokoka za najmanje 50 %.
English: Blood and lymphatic system disorders: Lymphadenopathy (localised to the region of the vaccination-site)
Croatian: Poremećaji krvi i limfnog sustava: limfadenopatija (lokalizirana na regiju primjene cjepiva)
English: • Seizures (or fits), including those caused by a high temperature
Croatian: • napadaji (ili konvulzije), uključujući i one prouzročene povišenom tjelesnom temperaturom
English: Pneumonia is the most common clinical presentation of pneumococcal disease in adults.
Croatian: Upala pluća je najčešća klinička slika pneumokokne bolesti u odraslih.
English: Detailed information on this product is available on the European Medicines Agency website: http://www.ema.europa.eu.
Croatian: Detaljne informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove: http://www.ema.europa.eu.
English: • Severe allergic reaction including shock (cardiovascular collapse); angioedema (swelling of lips, face or throat)
Croatian: • teška alergijska reakcija uključujući šok (kardiovaskularni kolaps); angioedem (otečenost usana, lica ili grla)
English: Significant incidence reductions were also observed in older age groups who had not been vaccinated with Prevenar 13 (indirect effect).
Croatian: Značajno smanjenje pojavnosti također je primijećeno u starijim dobnim skupinama koja nisu cijepljena Prevenarom 13 (neizravan učinak).
English: What Prevenar 13 is and what it is used for
Croatian: Što je Prevenar 13 i za što se koristi
English: The incidence in older, predominantly non-vaccinated children (>5 years) did not change over the duration of the study.
Croatian: Učestalost u starije, uglavnom necijepljene djece (>5 godina) nije se mijenjala tijekom trajanja ispitivanja.
English: Your child will receive an initial course of three injections.
Croatian: Vaše dijete će primiti početnu seriju cijepljenja od tri injekcije.
English: Safety in 354 previously unvaccinated children (7 months to 5 years of age) was also assessed.
Croatian: Bila je procijenjena i sigurnost u 354 prethodno necijepljene djece (u dobi od 7 mjeseci do 5 godina).
English: First episode analysis
Croatian: Analiza prve epizode
English: For serotype 6A
Croatian: Za serotip 6A
English: Safety and immunogenicity data for Prevenar 13 are not available for individuals in other specific immuno-compromised groups (e.g., malignancy or nephrotic syndrome) and vaccination should be considered on an individual basis.
Croatian: Podaci o sigurnosti i imunogenosti Prevenara 13 nisu dostupni za pojedince u drugim specifično imunokompromitiranim skupinama (npr., zloćudna bolest ili nefrotski sindrom) i tu cijepljenje treba razmotriti na individualnoj razini.
English: This vaccine should not be given as an intramuscular injection to individuals with thrombocytopaenia or any coagulation disorder that would contraindicate intramuscular injection, but may be given subcutaneously if the potential benefit clearly outweighs the risks (see section 5.1).
Croatian: Ovo se cjepivo ne smije primijeniti u obliku intramuskularne injekcije osobama s trombocitopenijom ili nekim poremećajem koagulacije koji predstavlja kontraindikaciju za intramuskularnu injekciju, ali može se dati supkutano ako je moguća korist jasno veća od rizika (vidjeti dio 5.1).
English: 18-49 Years N=836-866
Croatian: 18-49-godišnjaci N=836-866
English: The use of Prevenar 13 should be determined on the basis of official recommendations taking into consideration the risk of invasive disease and pneumonia in different age groups, underlying comorbidities as well as the variability of serotype epidemiology in different geographical areas.
Croatian: O primjeni Prevenara 13 treba odlučiti na temelju službenih preporuka, uzimajući pritom u obzir rizik invazivne bolesti i upale pluća u različitih dobnih skupina, prisutne dodatne bolesti kao i razlike u epidemiologiji serotipova u različitim geografskim područjima.
English: For vaccine serotypes, protection against otitis media is expected to be lower than protection against invasive disease.
Croatian: Za serotipove u cjepivu, očekuje se da će zaštita od upale srednjeg uha biti znatno niža od zaštite od invazivne bolesti.
English: The reductions ranged between 34% and 62% depending on serotype and antibiotic.
Croatian: Smanjenja su bila između 34% i 62%, ovisno o serotipu i antibiotiku.
English: 5 to 64 years of age
Croatian: 5 do 64 godina
English: For all pivotal clinical trials, a serotype-specific opsonophagocytosis assay (OPA) was used as a surrogate to assess potential efficacy against invasive pneumococcal disease and pneumonia.
Croatian: Sva ključna klinička ispitivanja koristila su se testom serotipski specifične opsonizacije i fagocitoze (OPA) kao surogatom za procjenu moguće djelotvornosti protiv invazivne pneumokokne bolesti i upale pluća.
English: For 6 of the remaining 7 common serotypes, similar rates of NP acquisition were observed in both vaccine groups; for serotype 19F a significant reduction was observed.
Croatian: Kod 6 od preostalih 7 zajedničkih serotipova primijećene su slične stope nazofaringealnog kliconoštva kod obje vakcinacijske skupine; kod serotipa 19F primijećeno je značajno smanjenje.
English: Children < 2 years of age.
Croatian: Djeca < 2 godine.
English: Efficacy was demonstrated for the primary and secondary endpoints in the per protocol population (Table 5).
Croatian: Djelotvornost je dokazana za mjere primarnog i sekundarnih ishoda u populaciji predviđenoj protokolom ispitivanja (tablica 5).
English: Prevenar 13 is a pneumococcal vaccine given to:
Croatian: Prevenar 13 je pneumokokno cjepivo koje se daje:
English: There was no carriage of serotypes 1 and 5 observed.
Croatian: Nije zabilježeno kliconoštvo serotipova 1 i 5.
English: However, some of the effects mentioned under section 4 “Possible side effects” may temporarily affect the ability to drive or use machines.
Croatian: Međutim, neki od učinaka spomenutih u dijelu 4. „Moguće nuspojave“ mogu privremeno utjecati na sposobnost upravljanja vozilima i rada sa strojevima.
English: Adults 18 to 49 years of age
Croatian: Odrasli u dobi od 18 do 49 godina
English: 5 to 45
Croatian: 5 do 45
English: 5 to 37
Croatian: 5 do 37
English: Prevenar (7-valent vaccine) protective efficacy in infants and children
Croatian: Djelotvornost zaštite Prevenarom (7-valentno cjepivo) u dojenčadi i djece
English: After first use, the product may be stored in a refrigerator for a maximum of 28 days.
Croatian: Nakon prve primjene, lijek se može pohraniti u hladnjaku tijekom najviše 28 dana.
English: Vaccines were administered at 1 month intervals.
Croatian: Cjepiva su primjenjivana u jednomjesečnim intervalima.
English: Prevenar 13 50-59 Relative to 60-64 Years
Croatian: Prevenar 13 50-59 godišnjaci u odnosu na 60-64-godišnjake
English: • 4.4 µg of polysaccharide for serotype 6B
Croatian: • 4,4 µg polisaharida za serotip 6B
English: Additional serotypes covered by Prevenar 13
Croatian: Dodatni serotipovi pokriveni Prevenarom 13
English: Prevenar 13 was administered to 48,806 adults; 2,616 (5.4%) aged 50 to 64 years, and 45,291 (92.8%) aged 65 years and older.
Croatian: Prevenar 13 bio je primijenjen u 48 806 odraslih osoba; 2616 (5,4 %) u dobi od 50 do 64 godine i 45 291 (92,8 %) u dobi od 65 ili više godina.
English: Furthermore, in this study statistically significantly greater OPA GMTs were demonstrated for 10 of the 12 serotypes in common.
Croatian: Nadalje, u tom su ispitivanju bile dokazane statistički značajno veće geometrijske sredine OPA titara za 10 od 12 zajedničkih serotipova.
English: Diarrhoea; vomiting (in adults aged 18 to 49 years)
Croatian: proljev; povraćanje (u odraslih u dobi od 18 do 49 godina)
English: A significant increase was seen in the concentrations of antibodies against the seven serotypes after the polysaccharide vaccination, suggesting that immunological memory was well established.
Croatian: Opaženo je značajno povišenje koncentracije protutijela protiv svih sedam serotipova nakon cijepljenja polisaharidnim cjepivom, što ukazuje na to da je uspostavljena dobra imunološka memorija.
English: At the end of this period Prevenar 13 should be used or discarded.
Croatian: Pri isteku ovog perioda Prevenar 13 treba primijeniti ili odložiti u otpad.
English: Responses to the booster dose administered at 12 months were unaffected.
Croatian: Odgovori na dozu docjepljivanja primijenjenu u dobi od 12 mjeseci bili su nepromijenjeni.